BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.96) EPS for the quarter, missing analysts’ consensus estimates of ($0.87) by ($0.09), Briefing.com reports. The company had revenue of $1.74 million for the quarter, compared to the consensus estimate of $4.78 million. The firm’s revenue for the quarter […]
Related Keywords
Frank Mccormick , Randalw Scott , Bridgebio Pharma , Bio Pharma , Cantor Fitzgerald , Topco Ltd , Bridgebio Pharma Company Profile , Wells Fargo Company , Ameritas Investment Partners Inc , Citigroup , Securities Exchange Commission , Bridgebio Pharma Inc , Get Free Report , Wells Fargo , Director Randal , Exchange Commission , Director Frank Mccormick , Investment Partners , Bridgebio Pharma Daily , Nasdaq Bbio , Ebbio , Medical , Earnings ,
comparemela.com © 2020. All Rights Reserved.